• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心性浆液性脉络膜视网膜病变患者血浆血管内皮生长因子和色素上皮衍生因子水平的变化

Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy.

作者信息

Chrząszcz Michał, Pociej-Marciak Weronika, Żuber-Łaskawiec Katarzyna, Romanowska-Dixon Bożena, Sanak Marek, Michalska-Małecka Katarzyna, Petrovič Mojca Globočnik, Karska-Basta Izabella

机构信息

Clinic of Ophthalmology and Ocular Oncology, Department of Ophthalmology, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Kraków, Poland.

Molecular Biology and Clinical Genetics Unit, Department of Internal Medicine, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Kraków, Poland.

出版信息

Medicina (Kaunas). 2021 Oct 5;57(10):1063. doi: 10.3390/medicina57101063.

DOI:10.3390/medicina57101063
PMID:34684100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8540423/
Abstract

Retinal pigment epitheliopathy and hyperpermeability of choroidal vessels were postulated to be involved in the pathogenesis of central serous chorioretinopathy (CSC). Imbalanced levels of vascular endothelial growth factor (VEGF) and pigment-epithelium-derived factor (PEDF) were previously implicated in the development of chorioretinal diseases characterized by increased vascular permeability. We aimed to compare the plasma levels of proangiogenic VEGF and antiangiogenic PEDF for 26 patients with acute CSC, 26 patients with chronic CSC, and 19 controls. VEGF and PEDF levels were measured using a multiplex immunoassay or enzyme-linked immunosorbent assay. Correlations with disease duration were assessed. VEGF levels differed between groups ( = 0.001). They were lower in patients with acute CSC ( = 0.042) and chronic CSC ( = 0.018) than in controls. PEDF levels were similar in all groups. The VEGF-to-PEDF ratio was lower in CSC patients than in controls ( = 0.04). A negative correlation with disease duration was noted only for PEDF levels in the group with chronic CSC (rho = -0.46, = 0.017). Our study confirmed that patients with CSC have imbalanced levels of VEGF and PEDF. This finding may have important implications for the pathogenesis of CSC. VEGF-independent arteriogenesis rather than angiogenesis may underlie vascular abnormalities in these patients.

摘要

视网膜色素上皮病变和脉络膜血管高通透性被认为与中心性浆液性脉络膜视网膜病变(CSC)的发病机制有关。血管内皮生长因子(VEGF)和色素上皮衍生因子(PEDF)水平失衡先前被认为与以血管通透性增加为特征的脉络膜视网膜疾病的发生有关。我们旨在比较26例急性CSC患者、26例慢性CSC患者和19例对照者的促血管生成VEGF和抗血管生成PEDF的血浆水平。使用多重免疫测定或酶联免疫吸附测定法测量VEGF和PEDF水平。评估与病程的相关性。各组之间VEGF水平存在差异(=0.001)。急性CSC患者(=0.042)和慢性CSC患者(=0.018)的VEGF水平低于对照组。所有组的PEDF水平相似。CSC患者的VEGF与PEDF比值低于对照组(=0.04)。仅在慢性CSC组中观察到PEDF水平与病程呈负相关(rho=-0.46,=0.017)。我们的研究证实,CSC患者的VEGF和PEDF水平失衡。这一发现可能对CSC的发病机制具有重要意义。这些患者血管异常的基础可能是不依赖VEGF的动脉生成而非血管生成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9c7/8540423/e4f3f6e408f1/medicina-57-01063-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9c7/8540423/26eb43887dea/medicina-57-01063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9c7/8540423/47c8e4384646/medicina-57-01063-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9c7/8540423/11bd2c093df7/medicina-57-01063-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9c7/8540423/e4f3f6e408f1/medicina-57-01063-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9c7/8540423/26eb43887dea/medicina-57-01063-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9c7/8540423/47c8e4384646/medicina-57-01063-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9c7/8540423/11bd2c093df7/medicina-57-01063-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9c7/8540423/e4f3f6e408f1/medicina-57-01063-g004.jpg

相似文献

1
Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变患者血浆血管内皮生长因子和色素上皮衍生因子水平的变化
Medicina (Kaunas). 2021 Oct 5;57(10):1063. doi: 10.3390/medicina57101063.
2
Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation.玻璃体内注射雷珠单抗对近视性脉络膜新生血管患者房水中血管内皮生长因子和色素上皮衍生因子浓度的影响。
Br J Ophthalmol. 2015 Jul;99(7):1004-8. doi: 10.1136/bjophthalmol-2014-306465. Epub 2015 Mar 13.
3
Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy.急性和慢性中心性浆液性脉络膜视网膜病变患者血管生成因子水平的失衡
J Clin Med. 2021 Mar 5;10(5):1087. doi: 10.3390/jcm10051087.
4
Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration.老年人类脉络膜及年龄相关性黄斑变性眼中的色素上皮衍生因子(PEDF)和血管内皮生长因子(VEGF)
Exp Eye Res. 2006 Jan;82(1):99-110. doi: 10.1016/j.exer.2005.05.007. Epub 2005 Jul 12.
5
Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD.尼古丁增加视网膜色素上皮细胞中的 VEGF/PEDF 比值:AMD 被动吸烟者 CNV 的可能机制。
Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3842-53. doi: 10.1167/iovs.10-6254.
6
Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration.雷珠单抗单药或联合维替泊芬治疗渗出性年龄相关性黄斑变性后房水血管内皮生长因子和色素上皮衍生因子的变化
Am J Ophthalmol. 2009 Nov;148(5):718-724.e1. doi: 10.1016/j.ajo.2009.06.012. Epub 2009 Aug 11.
7
Association of Upregulated Angiogenic Cytokines With Choroidal Abnormalities in Chronic Central Serous Chorioretinopathy.上调的血管生成细胞因子与慢性中心性浆液性脉络膜视网膜病变脉络膜异常的关系。
Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5924-5931. doi: 10.1167/iovs.18-25517.
8
Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis.抗血管内皮生长因子药物治疗中心性浆液性脉络膜视网膜病变的临床疗效:一项荟萃分析。
Int J Clin Pharm. 2017 Jun;39(3):514-521. doi: 10.1007/s11096-017-0460-4. Epub 2017 Apr 6.
9
Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo.香烟烟雾相关的对苯二酚可使体外和体内视网膜色素上皮细胞中 MCP-1、VEGF 和 PEDF 的表达失调。
PLoS One. 2011 Feb 28;6(2):e16722. doi: 10.1371/journal.pone.0016722.
10
Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.在年龄相关性黄斑变性导致的脉络膜新生血管患者的玻璃体中,色素上皮衍生因子缺乏。
Am J Ophthalmol. 2002 Aug;134(2):220-7. doi: 10.1016/s0002-9394(02)01549-0.

引用本文的文献

1
Quantitative analysis of choroidal vascular structures and anatomical changes in pachychoroid spectrum diseases using ultra-widefield SS-OCTA.使用超广角SS-OCTA对厚脉络膜谱系疾病中脉络膜血管结构及解剖学变化进行定量分析。
Sci Rep. 2025 Jan 2;15(1):344. doi: 10.1038/s41598-024-82745-5.
2
Role of Plasma Angiopoietin-1 and VEGF Levels as Potential Biomarkers in Chronic Central Serous Chorioretinopathy with Macular Neovascularization.血浆血管生成素-1 和 VEGF 水平作为慢性中心性浆液性脉络膜视网膜病变伴黄斑新生血管潜在生物标志物的作用。
Int J Mol Sci. 2024 Oct 6;25(19):10748. doi: 10.3390/ijms251910748.
3
The role of inflammation in central serous chorioretinopathy: From mechanisms to therapeutic prospects.

本文引用的文献

1
Altered serum levels of autophagy proteins Beclin-1 and mTOR in patients with exudative age-related macular degeneration.在渗出性年龄相关性黄斑变性患者中,自噬蛋白 Beclin-1 和 mTOR 的血清水平发生改变。
J Physiol Pharmacol. 2021 Feb;72(1). doi: 10.26402/jpp.2021.1.09. Epub 2021 Feb 21.
2
Quality of life of patients with central serous chorioretinopathy - a major cause of vision threat among middle-aged individuals.中心性浆液性脉络膜视网膜病变患者的生活质量——中年人群视力威胁的主要原因。
Arch Med Sci. 2020 Jan 29;17(3):724-730. doi: 10.5114/aoms.2020.92694. eCollection 2021.
3
Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy.
炎症在中心性浆液性脉络膜视网膜病变中的作用:从机制到治疗前景
Front Pharmacol. 2024 May 21;15:1200492. doi: 10.3389/fphar.2024.1200492. eCollection 2024.
4
Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China.玻璃体内注射抗血管内皮生长因子药物阿柏西普与亚阈值微脉冲激光治疗慢性中心性浆液性脉络膜视网膜病变:中国携带型维替泊芬短缺的替代治疗方案。
Ann Med. 2023 Dec;55(1):2227424. doi: 10.1080/07853890.2023.2227424.
5
Detection of macular ganglion cell complex loss and correlation with choroidal thickness in chronic and recurrent central serous chorioretinopathy.慢性复发性中心性浆液性脉络膜视网膜病变中黄斑神经节细胞复合体丢失的检测及其与脉络膜厚度的相关性
Int J Ophthalmol. 2023 Apr 18;16(4):579-588. doi: 10.18240/ijo.2023.04.12. eCollection 2023.
6
Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification.中心性浆液性脉络膜视网膜病变:病理生理学、全身关联及一种新的病因分类
Taiwan J Ophthalmol. 2022 Dec 5;12(4):381-393. doi: 10.4103/2211-5056.362601. eCollection 2022 Oct-Dec.
7
The Efficacy of Anti-VEGF Therapy for Putative or Visible CNV in Central Serous Chorioretinopathy by Optical Coherence Tomography Angiography.光学相干断层扫描血管造影评估抗VEGF治疗中心性浆液性脉络膜视网膜病变中推定或可见脉络膜新生血管的疗效
J Ophthalmol. 2022 Sep 28;2022:1272524. doi: 10.1155/2022/1272524. eCollection 2022.
急性和慢性中心性浆液性脉络膜视网膜病变患者血管生成因子水平的失衡
J Clin Med. 2021 Mar 5;10(5):1087. doi: 10.3390/jcm10051087.
4
Pachychoroid: current concepts on clinical features and pathogenesis.厚脉络膜病变:关于临床特征和发病机制的当前概念
Graefes Arch Clin Exp Ophthalmol. 2021 Jun;259(6):1385-1400. doi: 10.1007/s00417-020-04940-0. Epub 2020 Oct 15.
5
Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy.急性和慢性中心性浆液性脉络膜视网膜病变患者血浆细胞因子水平的改变。
Acta Ophthalmol. 2021 Mar;99(2):e222-e231. doi: 10.1111/aos.14547. Epub 2020 Jul 23.
6
Pigment Epithelium-Derived Factor as a Possible Treatment Agent for Choroidal Neovascularization.色素上皮衍生因子作为脉络膜新生血管治疗药物的可能性。
Oxid Med Cell Longev. 2020 Mar 6;2020:8941057. doi: 10.1155/2020/8941057. eCollection 2020.
7
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.预测慢性中心性浆液性脉络膜视网膜病变继发脉络膜新生血管对玻璃体内抗血管内皮生长因子(抗 VEGF)治疗的反应的因素。
Br J Ophthalmol. 2020 Jul;104(7):910-916. doi: 10.1136/bjophthalmol-2019-314625. Epub 2019 Oct 15.
8
Central serous chorioretinopathy: Towards an evidence-based treatment guideline.中心性浆液性脉络膜视网膜病变:迈向基于证据的治疗指南。
Prog Retin Eye Res. 2019 Nov;73:100770. doi: 10.1016/j.preteyeres.2019.07.003. Epub 2019 Jul 15.
9
Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study.早期治疗中心性浆液性脉络膜视网膜病变合并脉络膜新生血管:OCT-angiography 研究。
Eye (Lond). 2019 Nov;33(11):1809-1817. doi: 10.1038/s41433-019-0511-2. Epub 2019 Jul 2.
10
Autophagy: a new mechanism for regulating VEGF and PEDF expression in retinal pigment epithelium cells.自噬:视网膜色素上皮细胞中调节血管内皮生长因子和色素上皮衍生因子表达的新机制。
Int J Ophthalmol. 2019 Apr 18;12(4):557-562. doi: 10.18240/ijo.2019.04.05. eCollection 2019.